Business Context and Reporting Period
This Form 8-K was filed by EFOODSAFETY.COM, INC. (not Pharmacyte Biotech, Inc.) on September 29, 2005. The report discloses a corporate governance change involving the appointment of a new director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements.
Material Changes
- Director Appointment: Dr. Richard Marc Goldberg, M.D., FACS, was appointed as a director on September 29, 2005, to serve until a successor is chosen.
- Executive Role: Dr. Goldberg will continue serving as President and Chief Executive Officer of the company's recently acquired subsidiary, MedElite, Inc.
- Background: Dr. Goldberg has 13 years of experience in private practice as a general, vascular, and trauma surgeon and serves as Medical Director of Research and Development for the Bucks County Clinical Research Center.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or specific risk factors. Management commentary is limited to the background of the new director and the nature of his appointment. It is noted that while no proposed transactions exist between the Company and Dr. Goldberg, he is expected to participate in the Company's stock option plans. The filing states there are no arrangements or understandings with other persons regarding his appointment.
Investor Verification Checklist
- Verify the registrant name is EFOODSAFETY.COM, INC., not Pharmacyte Biotech, Inc.
- Confirm the status of the MedElite, Inc. acquisition and its integration into the parent company.
- Review future filings for details on Dr. Goldberg's committee assignments and stock option grants.
- Check subsequent financial reports for the impact of the MedElite acquisition on the company's financial position.